Plenary Keynote Sessions
Monday, August 24
1:35 Chairperson’s Remarks
John Sterling, MA, Editor in Chief, Genetic Engineering & Biotechnology News (GEN)
1:40 BioTechnology Product Development: Meeting Today’s Challenges While Planning for Tomorrow
Nicholas Warne, PhD, Vice President, Pharmaceutical Research and Development, BioTherapeutics Pharmaceutical Sciences, Pfizer Inc.
2:05 Speaker to be Announced
Wednesday, August 26
1:50 Chairperson’s Remarks
Dominic Clarke, PhD, ISCT Process & Product Committee; Co-Chair and Global Head, Cell Therapy, HemaCare Corp.
1:55 Scaling Cell and Gene Therapy: Challenges and Opportunities in Process Development and Manufacturing
Susan Fugett Abu-Absi, PhD, Senior Vice President, Pharmaceutical Development & Technology, bluebird bio, Inc.
2:20 The Future of Gene Therapy Technical Development
James Warren, PhD, Vice President, Pharmaceutical Development; Leader, Biotechnology and Gene Therapy Development, Ultragenyx Pharmaceutical